Marriott Tina

CIK 00018564141 companySALT LAKE CITY, UT

SEC Profile

Transactions

Companies

Filings

CIK

0001856414

Recent Transactions

50 trades

Tax Payment
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-11-15$6.17/sh−14,286→ 506,852 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-10-24$6.31/sh−6,000→ 521,138 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-10-24$1.06/sh+6,000→ 527,138 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2024-10-24−6,000→ 452,000 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-09-26$1.06/sh+6,000→ 527,138 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-09-26$7.00/sh−6,000→ 521,138 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2024-09-26−0→ 458,000 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2024-08-29−6,000→ 464,000 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-08-29$7.56/sh−6,000→ 521,138 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-08-29$1.06/sh+6,000→ 527,138 total
Tax Payment
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-08-15$6.69/sh−14,319→ 521,138 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-07-25$8.13/sh−6,000→ 535,457 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2024-07-25−6,000→ 470,000 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-07-25$1.06/sh+6,000→ 541,457 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2024-06-27−6,000→ 476,000 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-06-27$1.06/sh+6,000→ 541,457 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-06-27$7.21/sh−6,000→ 535,457 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-05-30$8.78/sh−3,000→ 535,457 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-05-30$1.06/sh+3,000→ 538,457 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2024-05-30−0→ 482,000 total
Tax Payment
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-05-15$10.01/sh−9,998→ 533,233 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-04-25$1.06/sh+3,000→ 546,231 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-04-25$7.67/sh−3,000→ 543,231 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2024-04-25−3,000→ 485,000 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-03-21$10.70/sh−7,390→ 640,592 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2024-03-21−8,000→ 488,000 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-03-21$1.06/sh+8,000→ 647,982 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-03-21$11.34/sh−610→ 639,982 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-02-22$14.89/sh−8,000→ 639,982 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-02-22$1.06/sh+8,000→ 647,982 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2024-02-22−8,000→ 496,000 total
Tax Payment
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-02-15$12.43/sh−5,379→ 639,982 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2024-02-09+447,917→ 447,917 total
Tax Payment
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-02-09$10.09/sh−2,800→ 645,361 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-02-09+223,958→ 648,161 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-02-09+9,655→ 424,203 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-01-25$10.35/sh−8,000→ 414,548 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2024-01-25−8,000→ 504,000 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2024-01-25$1.06/sh+8,000→ 422,584 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-12-28$10.58/sh−8,000→ 414,548 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2023-12-28−8,000→ 512,000 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-12-28$1.06/sh+8,000→ 422,548 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-11-16$6.76/sh−3,000→ 413,404 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2023-11-16−3,000→ 520,000 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-11-16$1.06/sh+3,000→ 416,404 total
Tax Payment
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-11-15$7.18/sh−5,378→ 413,404 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2023-10-26−3,000→ 523,000 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-10-26$5.63/sh−3,000→ 418,782 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-10-26$1.06/sh+3,000→ 421,782 total
Exercise/Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-09-28$1.06/sh+3,000→ 421,782 total

Companies

RECURSION PHARMACEUTICALS, INC.
President and COO
$RXRX

Recent Filings

Address

41 S. RIO GRANDE STREET

SALT LAKE CITY, UT, 84101

View on SEC.gov